← FDA DRUG APPROVALS

FDA ANDA · ANDA076439

BRIMONIDINE TARTRATE

Sponsor: RISING

APPLICATION
ANDA076439
TYPE
ANDA
ORIGINAL APPROVAL
2006-03-14
LATEST ACTION
2016-10-10
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Prescription

Products

BRIMONIDINE TARTRATEPrescription
BRIMONIDINE TARTRATE 0.2% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2016-10-10Labeling · Supplement 1 · standardAP
2006-03-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →